What is the purpose of Risk Evaluation and Mitigation Strategies (REMS)?

The purpose of Risk Evaluation and Mitigation Strategies (REMS) is to monitor drugs with high risk compared to benefit ratios. REMS programs are implemented by the FDA to ensure that certain medications known to have significant risks are used safely. These strategies may include requirements for healthcare providers, pharmacists, and patients, such as specific patient education, laboratory testing, and monitoring protocols. The goal is to minimize the risks associated with certain drugs while still allowing patients access to necessary treatments.

Other options do not align with the function of REMS. For instance, enhancing medication advertising does not relate to risk management and often focuses on promoting drugs rather than ensuring their safe use. Providing low-cost medications is a goal of various health initiatives but not specifically tied to risk management. Tracking patient satisfaction, while important in healthcare, does not address the safety and risk concerns associated with high-risk medications. Therefore, the emphasis on monitoring and mitigating risks is central to the purpose of REMS.